Banzel/Inovelon(rufinamide), from Eisai, for treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in children four years and older has been...
The FDA has approved a supplemental New Drug Application (sNDA) for Banzel (rufinamide), from Eisai, as an adjunctive treatment of...